Stryker Corporation (SYK)
NYSE • Healthcare
April 2, 2026 at 20:00 UTC
About Stryker Corporation
Stryker Corporation is a medical technology company that develops implants, surgical equipment, and patient care solutions used in hospitals and ambulatory centers. Its focus is practical: help clinicians restore mobility, perform procedures with confidence, and manage recovery under clear protocols. Engineering teams work with surgeons and care staff to refine instruments and workflows so products fit existing routines. Manufacturing and quality systems aim for dependable availability once a therapy is adopted. Education, service, and digital tools support safe use over long lifecycles. The company operates across many regions and clinical settings, but the promise remains the same: devices and systems that integrate cleanly into real care, backed by training and support that keep operating rooms and wards prepared for the next case.
Analyst Ratings
Fundamentals & Financials
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Income Statement
Balance Sheet
Financial Highlights
Dividends History
Split History
Earnings Calendar
Technical Indicators
Stryker Corporation's Technical Indicators Summary
SYK appears bearish from a technical perspective as trend strength and momentum tilt negative while volume is supportive of selling. ADX signals a pronounced downtrend, MACD is negative and short- to medium-term averages sit above the price with the 200-day also overhead, creating layered resistance. Volatility is moderate and the pivot is close to the market, offering a nearby reference. Technical takeaway: Bearish — strong directional pressure and selling volume keep the technical bias negative.
| Indicator | Value |
|---|---|
RSI (14) | 37.03 |
Stochastic %K (14, 3, 3) | 28.89 |
CCI (20) | -70.51 |
WPR (14) | -66.46 |
Momentum (10) | -8.22 |
MFI | 34.64 |
MACD Level (12, 26) | -9.73 |
Bollinger Bands | $314.71 - $364.62 |
ATR (14) | $9.22 (2.78%) |
ADX (14) | 35.27 |
OBV | -23,250,100 |
Classic Pivot Point | $329.17 |
Fibonacci Pivot Point | $329.17 |
Exponential Moving Averages | $332.44 - $366.82(5 indicators) |
Simple Moving Averages | $330.02 - $370.33(5 indicators) |
Get premium market insights delivered directly to your inbox.
Today's Snapshot
By the bell, SYK remained somewhat elevated, with the 0.65% gap versus yesterday leaving it around 331.54. Closing turnover for SYK remained on the soft side, running 0.70× typical levels. SYK climbs as the company’s cyberattack recovery boosts investor optimism for earnings and margins.
Price Change
from $331.74 close
-$0.18
Trading Volume
Below avg (2.1M)
1.4M
vs S&P 500 Today
Outperforming Market
+2.03%
52-Week Position
Lower range
14.3%
Updated: April 3, 2026 at 20:09 UTC
Quote Summary
SYK Headlines
Citi Resets Life Sciences And MedTech Views
March 11, 2026
Quiet Compounders Lead 2025’s Year-End Market Tone
January 1, 2026